We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+18.56%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$2.64B
AUM Growth
+$339M
Cap. Flow
-$7.41M
Cap. Flow %
-0.28%
Top 10 Hldgs %
20.8%
Holding
1,624
New
126
Increased
859
Reduced
567
Closed
34

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.91M
2
EG icon
Everest Group
EG
+$1.19M
3
G icon
Genpact
G
+$1.15M
4
IWV icon
iShares Russell 3000 ETF
IWV
+$1.08M
5
PTON icon
Peloton Interactive
PTON
+$874K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$7.92M
2
LIN icon
Linde
LIN
+$7.11M
3
IMMU
Immunomedics Inc
IMMU
+$3.54M
4
NVCR icon
NovoCure
NVCR
+$2.24M
5
ALLE icon
Allegion
ALLE
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 24.92%
2 Healthcare 14.03%
3 Consumer Discretionary 12.5%
4 Financials 11.83%
5 Industrials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRRX
1551
DELISTED
DURECT Corp
DRRX
$66K ﹤0.01%
3,207
+56
+2% +$1.06K
FRO icon
1552
Frontline
FRO
$8.57B
$64K ﹤0.01%
10,218
+16
+0.2% +$103
AKBA icon
1553
Akebia Therapeutics
AKBA
$335M
$63K ﹤0.01%
22,384
+118
+0.5% +$345
CLVS
1554
DELISTED
Clovis Oncology, Inc.
CLVS
$62K ﹤0.01%
12,976
+58
+0.4% +$293
SM icon
1555
SM Energy
SM
$7.44B
$61K ﹤0.01%
+10,012
New +$33.8K
BDSI
1556
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$59K ﹤0.01%
14,023
+64
+0.5% +$247
ARAY icon
1557
Accuray
ARAY
$28.3M
$58K ﹤0.01%
13,871
+19
+0.1% +$70
IVR icon
1558
Invesco Mortgage Capital
IVR
$764M
$58K ﹤0.01%
1,707
+11
+0.6% +$341
HLX icon
1559
Helix Energy Solutions
HLX
$1.33B
$57K ﹤0.01%
13,532
+110
+0.8% +$367
CPRX
1560
DELISTED
Catalyst Pharmaceutical
CPRX
$50K ﹤0.01%
15,101
+90
+0.6% +$302
CALA
1561
DELISTED
Calithera Biosciences, Inc
CALA
$50K ﹤0.01%
513
+4
+0.8% +$351
NEX
1562
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$48K ﹤0.01%
13,905
VRAY
1563
DELISTED
ViewRay, Inc.
VRAY
$47K ﹤0.01%
12,319
ATHX
1564
DELISTED
Athersys, Inc. Common Stock
ATHX
$47K ﹤0.01%
1,077
+3
+0.3% +$136
SPPI
1565
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$45K ﹤0.01%
13,309
+81
+0.6% +$333
LITS
1566
Lite Strategy Inc
LITS
$32.4M
$42K ﹤0.01%
788
+45
+6% +$2.6K
TDAY
1567
USA Today Co
TDAY
$1.3B
$41K ﹤0.01%
12,327
+91
+0.7% +$188
TXMD icon
1568
TherapeuticsMD
TXMD
$23.6M
$41K ﹤0.01%
679
VSTM icon
1569
Verastem
VSTM
$518M
$41K ﹤0.01%
1,599
GERN icon
1570
Geron
GERN
$911M
$39K ﹤0.01%
24,487
NAT icon
1571
Nordic American Tanker
NAT
$1.34B
$36K ﹤0.01%
12,344
XPRO icon
1572
Expro Ltd
XPRO
$1.72B
$36K ﹤0.01%
2,208
ASAP
1573
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$36K ﹤0.01%
648
+4
+0.6% +$257
UEC icon
1574
Uranium Energy
UEC
$4.57B
$35K ﹤0.01%
20,116
AGRX
1575
DELISTED
Agile Therapeutics
AGRX
$29K ﹤0.01%
5

Similar funds

Amalgamated Bank's Q4 2020 Portfolio in Review

As of Q4 2020, Amalgamated Bank held 1,624 positions worth $2.64B, up 15% from $2.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Amalgamated Bank's Q4 2020 filing shows 126 new, 859 increased, 567 reduced and 34 closed positions. Its largest new stake was Everest Group: 5,388 shares worth $1.26M. The largest sale was Medtronic, an estimated $7.92M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Amalgamated Bank's largest Q4 2020 buy was Everest Group: 5,388 shares worth $1.26M.
  • Amalgamated Bank added most to Tesla in Q4 2020, an estimated $4.91M increase.
  • Amalgamated Bank's biggest Q4 2020 reduction was Apple, cutting an estimated $785K.
  • Amalgamated Bank fully exited Medtronic in Q4 2020, selling an estimated $7.92M.
  • Amalgamated Bank's ten largest holdings make up 21% of its $2.64B portfolio in Q4 2020.
  • Amalgamated Bank opened 126 new positions and closed 34 in Q4 2020.
  • Amalgamated Bank's portfolio value rose 15% quarter-over-quarter to $2.64B.

Based on Amalgamated Bank's 13F filing for Q4 2020, filed 12 Feb 2021.